Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types.

Genomic biomarkers and gene-signatures of specific tumor subtypes, selected according to their HR status and molecular features, could facilitate personalized biological-driven RT treatment planning alone and in combination with targeted therapies.